What keeps ophthalmologists up at night: Part III
January 13, 2021
From patient care and treating glaucoma to the ongoing pandemic, ophthalmologists share the most pressing thoughts of concern leaving them awake at night.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Expert Interviews
Managing ocular toxicities in myeloma
January 14, 2021
Shaily Shah, MD, Northern California Cornea Associates, shares pearls for ophthalmologists on managing ocular toxicities in patients with myeloma.
Dr. Mali: Top 5 predictions for ophthalmology in 2021
December 19, 2020
Joshua Mali, MD, speaks on his annual top 5 predictions in ophthalmology for what's to come in 2021.
Safety, efficacy of KPI-121 0.25% for DED treatment
December 18, 2020
Preeya Gupta, MD, discusses the results of a study evaluating the safety and efficacy of KPI-121 0.25% for the treatment of dry eye disease.
Visual outcomes of small-aperture IOL implant in post-laser refractive eyes
December 17, 2020
Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.
Success of SLT after trabecular bypass stenting / phaco
December 15, 2020
Richard Lehrer, MD, speaks on the highlights of a study analyzing the success of SLT after trabecular bypass stenting / phacoemulsification, presented during AAO 2020.
Analysis of investigational ophthalmic solution for treating presbyopia-related symptoms
December 13, 2020
Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.
Evaluating long-term safety of micro-bypass implant with phaco in PXG
December 12, 2020
Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Visual and non-visual benefits of violet light-filtering IOLs
December 10, 2020
Daniel H. Chang, MD, speaks on the highlights of his presentation on "Violet Light-Filtering IOLs: Visual and Non-Visual Benefits," during the virtual AAO 2020 meeting.
Drug delivery vs drops: Controlling postop pain, inflammation in cataract surgery patients
December 08, 2020
John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.